| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Rheumatology Research and Advanced Therapeutics, Department of Rheumatology,
Department of Biochemistry, Nijmegen Center for Molecular Life Sciences, and
Department of Orthopedic Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Dendritic cells (DCs) are specialized APCs that can be activated upon pathogen recognition as well as recognition of endogenous ligands, which are released during inflammation and cell stress. The recognition of exogenous and endogenous ligands depends on TLRs, which are abundantly expressed in synovial tissue from rheumatoid arthritis (RA) patients. Furthermore TLR ligands are found to be present in RA serum and synovial fluid and are significantly increased, compared with serum and synovial fluid from healthy volunteers and patients with systemic sclerosis and systemic lupus erythematosus. Identification of novel endogenous TLR ligands might contribute to the elucidation of the role of TLRs in RA and other autoimmune diseases. In this study, we investigated whether five members of the small heat shock protein (HSP) family were involved in TLR4-mediated DC activation and whether these small HSPs were present in RA synovial tissue. In vitro, monocyte-derived DCs were stimulated with recombinant 
A crystallin, B crystallin, HSP20, HSPB8, and HSP27. Using flow cytometry and multiplex cytokine assays, we showed that both A crystallin and HSPB8 were able to activate DCs and that this activation was TLR4 dependent. Furthermore, Western blot and immunohistochemistry showed that HSPB8 was abundantly expressed in synovial tissue from patients with RA. With these experiments, we identified sHSP A crystallin and HSPB8 as two new endogenous TLR4 ligands from which HSPB8 is abundantly expressed in RA synovial tissue. These findings suggest a role for HSPB8 during the inflammatory process in autoimmune diseases such as RA.
This article has been cited by other articles:
|
|
 |
|
  Q.-Q. Huang, R. Sobkoviak, A. R. Jockheck-Clark, B. Shi, A. M. Mandelin II, P. P. Tak, G. K. Haines III, C. V. Nicchitta, and R. M. Pope Heat Shock Protein 96 Is Elevated in Rheumatoid Arthritis and Activates Macrophages Primarily via TLR2 Signaling J. Immunol., April 15, 2009; 182(8): 4965 - 4973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yusuf, T. H. Nasti, C.-M. Huang, B. S. Huber, T. Jaleel, H.-Y. Lin, H. Xu, and C. A. Elmets Heat Shock Proteins HSP27 and HSP70 Are Present in the Skin and Are Important Mediators of Allergic Contact Hypersensitivity J. Immunol., January 1, 2009; 182(1): 675 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chao Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Simmonds and B. M. Foxwell Signalling, inflammation and arthritis: NF-{kappa}B and its relevance to arthritis and inflammation Rheumatology, May 1, 2008; 47(5): 584 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R D J Radstake, J. Fransen, E. J M Toonen, M. J H Coenen, A. E Eijsbouts, R. Donn, F. H J van den Hoogen, and P. L C M van Riel Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor {alpha}-neutralising treatments in rheumatoid arthritis Ann Rheum Dis, November 1, 2007; 66(11): 1525 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Leaphart, J. Cavallo, S. C. Gribar, S. Cetin, J. Li, M. F. Branca, T. D. Dubowski, C. P. Sodhi, and D. J. Hackam A Critical Role for TLR4 in the Pathogenesis of Necrotizing Enterocolitis by Modulating Intestinal Injury and Repair J. Immunol., October 1, 2007; 179(7): 4808 - 4820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Gondokaryono, H. Ushio, F. Niyonsaba, M. Hara, H. Takenaka, S. T. M. Jayawardana, S. Ikeda, K. Okumura, and H. Ogawa The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4 J. Leukoc. Biol., September 1, 2007; 82(3): 657 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G Walker, M J Ahern, M Coleman, H Weedon, V Papangelis, D Beroukas, P J Roberts-Thomson, and M D Smith Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritis Ann Rheum Dis, August 1, 2007; 66(8): 992 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-F. Tsan and Baochong Gao Review: Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors Innate Immunity, February 1, 2007; 13(1): 6 - 14. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Bachleitner-Hofmann, M. Strohschneider, P. Krieger, M. Sachet, P. Dubsky, H. Hayden, S. F. Schoppmann, R. Pfragner, M. Gnant, J. Friedl, et al. Heat Shock Treatment of Tumor Lysate-Pulsed Dendritic Cells Enhances Their Capacity to Elicit Antitumor T Cell Responses against Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4571 - 4577. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
